These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature. Lorentz K; Booken N; Goerdt S; Goebeler M J Dtsch Dermatol Ges; 2008 Oct; 6(10):823-7, 823-8. PubMed ID: 18564209 [TBL] [Abstract][Full Text] [Related]
16. Lupus erythematosus induced by medications, ultraviolet radiation, and other exogenous agents: a review, with special focus on the development of subacute cutaneous lupus erythematosus in a genetically predisposed individual. Shapiro M; Sosis AC; Junkins-Hopkins JM; Werth VP Int J Dermatol; 2004 Feb; 43(2):87-94. PubMed ID: 15125497 [TBL] [Abstract][Full Text] [Related]
17. Subacute cutaneous lupus erythematosus as a rare complication of disease-modifying therapy administration in multiple sclerosis: case report. Xu K; Zhang M; Yang S; Yu G; Zheng P; Qin X; Feng J BMC Neurol; 2023 Apr; 23(1):168. PubMed ID: 37101279 [TBL] [Abstract][Full Text] [Related]
18. Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden. Grönhagen CM; Fored CM; Linder M; Granath F; Nyberg F Br J Dermatol; 2012 Aug; 167(2):296-305. PubMed ID: 22458771 [TBL] [Abstract][Full Text] [Related]